Trading approval received for 82 lakh equity shares allotted on warrant conversion
Akme Fintrade (India) Ltd has received trading approval from NSE and BSE for 82 lakh equity shares of Rs. 1 each, allotted to Promoter and Non-Promoter on preferential basis after conversion of warrants.
By ScoutQuest · · 1 min read
- Shares Approved for Trading
- 82 lakh equity shares of Rs. 1 each
- Allotment Basis
- Preferential basis after conversion of warrants
- Updated Listed Capital
- Rs. 44,79,49,960 (~44.79 crore fully paid shares of Rs. 1 each)
Trading approval for converted warrants
- Akme Fintrade (India) Ltd has received trading approval from the National Stock Exchange of India Limited and BSE Limited for 82 lakh equity shares.
- These shares carry a face value of Rs. 1/- each and were allotted to Promoter and Non-Promoter allottees on a preferential basis.
- The allotment followed the conversion of warrants issued on a preferential basis under Chapter V of the SEBI (ICDR) Regulations, 2018.
- The trading approval letters from both exchanges are dated October 29, 2026.
What this means for the share capital
- With these approvals in hand, the shares allotted on conversion become available for trading on the exchanges.
- The update states that the listed capital of the Company has increased to Rs. 44,79,49,960, represented by ~44.79 crore fully paid equity shares of Rs. 1 each.
- In simple terms, the total pool of listed shares is now 44,79,49,960, and the 82 lakh shares covered by this approval form part of that pool.
Why investors track such updates
- Warrant conversion means shares that were earlier only allotted now become tradable, which adds to the number of shares in the market.
- A preferential allotment to promoters and non-promoters changes the shareholding pattern, and this update records that the shares are now tradeable.
- The update gives the updated listed capital, which lets an investor compare the new share count with earlier disclosures.
Also from Akme Fintrade (India)
Board approves unaudited Q2/H1 FY27 results; related party transaction statement for the half year shared
30 Oct 2026
No deviation or variation in use of issue proceeds; Q2 and H1 standalone results approved
30 Oct 2026
Board meeting outcome: standalone Q2 and H1 FY27 results approved, auditor review unmodified
30 Oct 2026
More numbers
- Equity shares for which trading approval received82,00,000
- Face value per equity shareRs. 1/-
- Listed capital after trading approvalRs. 44,79,49,960
- Fully paid equity shares of Rs. 1 each44,79,49,960
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.